Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease

You'll see more attention paid to the management of nonalcoholic fatty liver disease (NAFLD)...as it becomes more common.

Up to 100 million Americans have this buildup of fat in the liver...usually without any symptoms. It often goes hand in hand with obesity, dyslipidemia, insulin resistance, and diabetes.

About 20% of patients with NAFLD have nonalcoholic steatohepatitis (NASH)...the more severe form with inflammation and sometimes fibrosis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote